Work

0724 Safety and Efficacy of the Orexin 2 Receptor Agonist Alixorexton in Patients with Narcolepsy Type 1: The Phase 2 Vibrance-1 Study

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0723

Authors: Giuseppe Plazzi, Ron Grunstein, Emmanuel Mignot, Gert Jan Lammers, David Plante, Erik Buntinx, Rafael Del Rio Villegas, Hailu Chen, Alexandra Lovett, Craig Hopkinson, Bhaskar Rege, Julie Himes, Yves Dauvilliers

Institutions: Istituto delle Scienze Neurologiche di Bologna, Woolcock Institute of Medical Research, Macquarie University, Stanford Medicine, Stanford University, Leiden University Medical Center, University of Wisconsin–Madison, Alkermes (United States), Inserm, Université de Montpellier, Hôpital Gui de Chauliac, Institute for Neurosciences of Montpellier

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160640419

FWCI:

Cites:

Cited by:

Related to: